Literature DB >> 6811006

Nebulised salbutamol and angina.

E Neville, P A Corris, J Vivian, S Nariman, G J Gibson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811006      PMCID: PMC1499550          DOI: 10.1136/bmj.285.6344.796

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Aerosol salbutamol administration by IPPB: lowest effective dose.

Authors:  R E Ruffin; G Obminski; M T Newhouse
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

2.  Domiciliary nebulised salbutamol solution in severe chronic airway obstruction.

Authors:  R S Wilson; S J Connellan
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

3.  Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.

Authors:  E H Walters; A Cockroft; T Griffiths; K Rocchiccioli; B H Davies
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

4.  Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  Y F Choo-Kang; S S Parker; I W Grant
Journal:  Br Med J       Date:  1970-11-21
  4 in total
  19 in total

1.  Treatment for acute asthma in the ambulance.

Authors:  C G Wathen; G K Crompton; D Carrington; J Hollingworth
Journal:  Br J Gen Pract       Date:  1990-09       Impact factor: 5.386

2.  Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.

Authors:  Leyla Cekici; Arschang Valipour; Robab Kohansal; Otto Chris Burghuber
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

3.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

4.  Nebulisers for asthma.

Authors:  M J Ward
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

5.  Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.

Authors:  J Crane; C Burgess; R Beasley
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

6.  Use of anti-asthma drugs in New Zealand.

Authors:  B L Sinclair; D W Clark; M R Sears
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

7.  Cardiac effects of salbutamol given by air driven nebuliser at home.

Authors:  J J Gilmartin; D Veale; A Murray; P C Adams; G J Gibson
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

8.  Home nebulisers for airflow limitation.

Authors:  G M Cochrane; J G Prior; P J Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

9.  Dosage and delivery of nebulised beta agonists in hospital.

Authors:  J N Stainforth; R A Lewis; A E Tattersfield
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

Review 10.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.